Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=133ce355-c538-48f8-83ec-400bf8ad7ae6 Date 2/19/2014 Company Name Curoverse Mailing Address 332 Congress Street 4th Floor Boston, MA 02210 Company Description Curoverse is entirely built with open source software. At its core, Curoverse uses a free and open source system called Arvados that was first developed for the Harvard Personal Genome Project. Arvados is designed … Continue reading “Curoverse Garners $200,000 New Funding Round”
Category: Boston
Proteon Therapeutics Lands $4,338,660 New Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=69988c54-c071-4de0-b485-ace356868e6b Date 2/19/2014 Company Name Proteon Therapeutics Mailing Address 200 West Street Waltham, MA 02451 Company Description Proteon Therapeutics is a biopharmaceutical company developing PRT-201, a novel human recombinant protein that permanently dilates segments of blood vessels, blocks vasospasm, and reduces the formation of vascular scarring. Website http://www.proteontherapeutics.com Transaction Type Debt, Venture … Continue reading “Proteon Therapeutics Lands $4,338,660 New Financing Round”
Proteon Therapeutics Garners $4,338,660 New Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=69988c54-c071-4de0-b485-ace356868e6b Date 2/19/2014 Company Name Proteon Therapeutics Mailing Address 200 West Street Waltham, MA 02451 Company Description Proteon Therapeutics is a biopharmaceutical company developing PRT-201, a novel human recombinant protein that permanently dilates segments of blood vessels, blocks vasospasm, and reduces the formation of vascular scarring. Website http://www.proteontherapeutics.com Transaction Type Debt, Venture … Continue reading “Proteon Therapeutics Garners $4,338,660 New Financing Round”
Immuno-Oncology Fever Rages as Novartis Snaps Up CoStim
How much is Big Pharma salivating over cancer immunotherapy these days? CoStim Pharmaceuticals, a little startup just about a year removed from its first big funding round, has already been snatched up by Swiss pharma giant Novartis. Novartis has paid an undisclosed sum to acquire CoStim, a Cambridge, MA-based startup backed by MPM Capital, Atlas … Continue reading “Immuno-Oncology Fever Rages as Novartis Snaps Up CoStim”
Ex-Harvard Bio Prez Leads Spin-Off’s Plan to Make Engineered Organs
David Green had led Holliston, MA-based Harvard Bioscience (NASDAQ: [[ticker:HBIO]]) for almost two decades when he was faced with a big career choice. The company was about to spin off a new firm that would take with it an ambitious technology Harvard Bio had been developing to make engineered organs—a high-risk, high-reward project. Green had … Continue reading “Ex-Harvard Bio Prez Leads Spin-Off’s Plan to Make Engineered Organs”
Molecular Diagnostics Are in a Rut. The Industry Needs the FDA
Some of the more exciting ideas in biotech are coming up in molecular diagnostics. There’s cool science at work. A number of tests have potential to cut down on overtreatment, reduce waste in healthcare, and give physicians clever new ideas on how to help patients. But this industry, which accounts for less than 2 percent … Continue reading “Molecular Diagnostics Are in a Rut. The Industry Needs the FDA”
Novartis AG Acquires Costim Pharmaceuticals for Undisclosed Sum
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=9a659bac-b337-435e-94bd-3befd2e8fc49 Date 2/17/2014 Company Name Costim Pharmaceuticals Mailing Address 200 Clarendon Street 54th Floor Boston, MA 02116 Company Description The company is developing a focused and highly attractive pipeline of antibody agents directed to costimulatory targets for the treatment of cancer. Website http://www.costim.com Transaction Type M&A Transaction Amount Undisclosed Transaction Round Proceeds … Continue reading “Novartis AG Acquires Costim Pharmaceuticals for Undisclosed Sum”
Dunwello Secures $1,400,000 New Financing
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=390e039a-fb84-4ce1-bb2b-d9c29d5bc1a9 Date 2/15/2014 Company Name Dunwello Mailing Address 271 Dartmouth St. Boston, MA 02116 Company Description Dunwello is a stealth mode company building business productivity software. Website http://www.dunwello.com Transaction Type Venture Equity Transaction Amount $1,400,000 Transaction Round Undisclosed Proceeds Purposes Proceeds purposes were not disclosed. M&A Terms Venture Investor NextView Ventures Venture … Continue reading “Dunwello Secures $1,400,000 New Financing”
15 Places to Turn for Technology News That Really Matters
Nobody on their deathbed says they wish they’d spent more time reading tech blogs. Don’t get me wrong: It’s great that consumers and entrepreneurs have so many places today to get news about the world of Internet startups, mobile devices, software, and venture investing. Back in 1998-2001, the last time things were this crazy in … Continue reading “15 Places to Turn for Technology News That Really Matters”
East Coast Biotech Roundup: Voyager, Concert, Retrophin, & More
(Updated, 9:05 am ET) The East Coast got buried in snow this week—again—but biotech activity was raging regardless. More IPOs priced (of course). A new high-profile startup emerged from stealth. A small acquisition wowed Wall Street. Those headlines and more below: —Third Rock Ventures has had success so far with its first gene therapy portfolio … Continue reading “East Coast Biotech Roundup: Voyager, Concert, Retrophin, & More”
Boston Tech Roundup: Carbonite, BlueConic, CodeShip, Accelerators
This week saw the founder of a publicly traded tech company stepping down from his job, while some startups raised Series A rounds to relocate to Boston and local accelerators made some moves: —Carbonite founder David Friend is leaving his job as president and CEO of the online computer backup company. Carbonite (NASDAQ: [[ticker:CARB]]) said … Continue reading “Boston Tech Roundup: Carbonite, BlueConic, CodeShip, Accelerators”
BlueConic Receives $3,000,000 Series A Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=6df20772-a155-4ea9-9feb-f8b3e3c72fda Date 2/14/2014 Company Name BlueConic Mailing Address 470 Atlantic Avenue Boston, MA 02210 Company Description BlueConic helps brands optimize cross-channel marketing opportunities through improved customer engagement. Website http://www.blueconic.com Transaction Type Venture Equity Transaction Amount $3,000,000 Transaction Round Series A Proceeds Purposes BlueConic will use the funds to fuel aggressive expansion into … Continue reading “BlueConic Receives $3,000,000 Series A Financing Round”
Xconomy Forum: What’s Hot in Boston Biotech
This event is sold out, but we invite you to sign up for the event waitlist here. It’s no secret that biotech is feeling it once again. Stocks are way up, and startups are seizing the opportunity to sail through a wide-open IPO window. That bull market isn’t just generating big returns for investors, it’s … Continue reading “Xconomy Forum: What’s Hot in Boston Biotech”
Bit9 Buys Carbon Black, Gets $38M to Try to Win Security Arms Race
2014 is shaping up to be the year of cybersecurity. Or lack thereof. It seems every week we hear about a new data breach or major hacking operation. And every week there seems to be a new tech company trying to solve these problems. Bit9 is not one of them. The Waltham, MA-based company has … Continue reading “Bit9 Buys Carbon Black, Gets $38M to Try to Win Security Arms Race”
Concert Pharma Heads to Nasdaq, Prices IPO at $14 Per Share
What’s it worth to add a little deuterium to drugs to boost their abilities? In Wall Street’s eyes, about $14 per share. Lexington, MA-based Concert Pharmaceuticals will debut on the Nasdaq today after pricing its IPO at the top of its projected range of $14 per share. The company sold 6 million shares in the … Continue reading “Concert Pharma Heads to Nasdaq, Prices IPO at $14 Per Share”
Swirl Rolls Out `Indoor GPS’ at Alex and Ani Stores Nationwide
It’s one of those smartphone-era technology breakthroughs that you’re constantly hearing will happen very soon: an “indoor GPS” system for retailers, allowing shopkeepers to send their would-be customers digital coupons and other goodies tailored to the place they’re standing in the store. Brick-and-mortar retailers would probably like to start using these systems if they could … Continue reading “Swirl Rolls Out `Indoor GPS’ at Alex and Ani Stores Nationwide”
Char Software Obtains $14,710,750 New Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=243c24a6-0ca6-4f3e-ab1b-0709bfa60530 Date 2/13/2014 Company Name Char Software Mailing Address 141 Tremont Street 7th Floor Boston, MA 02111 Company Description Char Software, Inc. is a Boston based software company focused exclusively on building interactive web and mobile software for its clients and our team possesses deep technical and business experience in the mobile … Continue reading “Char Software Obtains $14,710,750 New Funding Round”
Bit9 Lands $38,250,000 New Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=24559273-72b9-4f0e-bf0e-73c459d1fee8 Date 2/13/2014 Company Name Bit9 Mailing Address 266 Second Ave Waltham, MA 02451 Company Description Bit9 is the first company to solve the problem of unwanted software at the endpoint. Website http://www.bit9.com Transaction Type Venture Equity Transaction Amount $38,250,000 Transaction Round Undisclosed Proceeds Purposes Bit9 also announced today it has raised … Continue reading “Bit9 Lands $38,250,000 New Financing Round”
Pronutria Lands $12,250,000 Series B Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=7f135ca5-c4b2-46e2-a543-8d710edf5852 Date 2/13/2014 Company Name Pronutria Mailing Address 840 Memorial Drive 3rd Floor Cambridge, MA 02139 Company Description Pronutria created a revolutionary platform for identifying protein nutrients from within the human diet that have potent pharmacological effects, opening a vast untapped source of safe, breakthrough medicines. Website http://www.pronutria.com Transaction Type Venture Equity … Continue reading “Pronutria Lands $12,250,000 Series B Financing Round”
Voyager Therapeutics Lands $45,000,000 Series A Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=bc133032-e65f-4645-99f1-ef6685c0731b Date 2/13/2014 Company Name Voyager Therapeutics Mailing Address 75 Sidney St. Cambridge, MA 02139 Company Description Voyager Therapeutics is developing life-changing gene therapies for fatal and debilitating diseases of the central nervous system. Our founders include scientific and clinical leaders in the fields of adeno-associated virus (AAV) gene therapy, expressed RNA … Continue reading “Voyager Therapeutics Lands $45,000,000 Series A Funding”
2014 NEVY Awards
New England Venture Capital Association’s annual awards gala brings together more than 700 entrepreneurs and venture capitalists to celebrate the greatest tech and healthcare hits of the last year. Information and registration here.
Lovelines Looking to Create Mobile Platform for Interactive Stories
Love is in the air. Men are falling for their operating systems, Fifty Shades of Grey is on its way to the silver screen, and women are finding romantic escapes through texting. This Valentine’s Day tech story is brought to you by Pink Kiwi, the Boston-area makers of a new iOS app called Lovelines. It’s … Continue reading “Lovelines Looking to Create Mobile Platform for Interactive Stories”
Flipping the Flipped Classroom
Two of the hot topics in education in the last few years have been Massive Open Online Courses (MOOC’s) and the flipped classroom. I’ve been experimenting with both of them. What I’ve learned (besides being able to use the word “pedagogy” in a sentence) is 1) assigning students lectures as homework doesn’t guarantee the students … Continue reading “Flipping the Flipped Classroom”
Third Rock’s Voyager Hunts For CNS Disorders With Gene Therapy
Several biotechs have tried over the years to come up with a way to reverse the course of crippling central nervous system disorders like amyotrophic lateral sclerosis (a.k.a. Lou Gehrig’s Disease), only to see their efforts fall short. Now, Third Rock Ventures will try to see if gene therapy can succeed where so many drugs … Continue reading “Third Rock’s Voyager Hunts For CNS Disorders With Gene Therapy”
Cybereason Lands $4,600,000 Series A Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=c522f663-0a05-49c9-849a-a6799bde4db7 Date 2/12/2014 Company Name Cybereason Mailing Address One Broadway 15th Floor Cambridge, MA 02142 Company Description Malops are malicious operations that are parts of a larger cyber attack. They represent discrete steps, from penetration to damage, with intermediate objectives – all aimed at the overall endgame operation. Detecting the attacker’s actions … Continue reading “Cybereason Lands $4,600,000 Series A Round”
Flexion Prices IPO at $13, Heads to Nasdaq Tomorrow
Flexion Therapeutics is set to become the latest biotech to debut on the Nasdaq. The Burlington, MA-based company, which is developing a group of osteoarthritis drugs, priced its IPO late Tuesday, becoming the 15th biotech to do so just a month into 2014. Flexion sold 5 million shares in the offering at $13 apiece, raising … Continue reading “Flexion Prices IPO at $13, Heads to Nasdaq Tomorrow”
Algae Biomass Advocates Push Past Exuberance, Aim for Sustainability
Ice shut down Houston for the second time in five days recently, a weather event that, in its sheer strangeness, seemed a fitting backdrop for a gathering of alternative fuel advocates in Big Oil’s backyard. I drove on an unusually empty Interstate 45 to Montgomery, TX, about 60 miles north of Houston, where the leaders … Continue reading “Algae Biomass Advocates Push Past Exuberance, Aim for Sustainability”
Age of Cybereason: Security Startup Out to Stop Hackers in the Act
Another month, another startup helping to keep Boston on the map as an epicenter of cybersecurity expertise. From CounterTack to Cyber-Ark to Co3, many companies have been making news in recent months. This time it’s Cybereason, an Israeli-born startup that has set up headquarters in Cambridge, MA, with help from Charles River Ventures, which put … Continue reading “Age of Cybereason: Security Startup Out to Stop Hackers in the Act”
Codeship Lands $3,200,428 New Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=92be3bf6-62da-46bf-b1d2-6f2535cdf0d4 Date 2/11/2014 Company Name Codeship Mailing Address 1 Cambridge Center 6th Floor Cambridge, MA 02142 Company Description We offer hosted continuous integration and deployment for your web apps. You have a rails, php, python, java or go project you want us to handle? Go ahead and give it a try. Website … Continue reading “Codeship Lands $3,200,428 New Financing Round”
New York Leads Boston in Tech Job Growth; Google, Wayfair at Top
Where is all the technology talent flowing in the Northeast? If you look at Internet and digital media companies, New York City has the edge over Boston at the moment. New York registered a 3.2 percent increase in those tech jobs last quarter, while job growth in Boston fell to 1.3 percent—the lowest it’s been … Continue reading “New York Leads Boston in Tech Job Growth; Google, Wayfair at Top”
The Young and Proven Biotech VCs From 2012. Where Are They Now?
One of the old saws in journalism is to “follow the money” when you’re looking for a story. But sometimes you learn even more by following the people. The people, in this case, are biotech venture capitalists. Regular readers of this column know that biotech VC has been going through a historic shakeout the last … Continue reading “The Young and Proven Biotech VCs From 2012. Where Are They Now?”
Melinta Therapeutics Obtains $70,000,000 Series C Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=7e991993-204a-4c76-a6f0-8e8df50d503f Date 2/10/2014 Company Name Melinta Therapeutics Mailing Address 300 George Street New Haven, CT 06511 Company Description Melinta Therapeutics’ mission is to discover, develop and commercialize groundbreaking antibiotics to overcome drug-resistant, life-threatening infections. Website http://www.melinta.com Transaction Type Venture Equity Transaction Amount $70,000,000 Transaction Round Series C Proceeds Purposes Proceeds from this … Continue reading “Melinta Therapeutics Obtains $70,000,000 Series C Round”
BioAegis Therapeutics Secures $3,732,412 New Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=1b3158e2-131b-4127-83bc-e4a482691b1a Date 2/10/2014 Company Name BioAegis Therapeutics Mailing Address Undisclosed Boston, MA 02108 Company Description BioAegis Therapeutics’ products will restore depleted levels of plasma gelsolin, an integral and ubiquitous, natural human protein, whose important clinical role is now emerging. Website http://www.bioaegistherapeutics.com Transaction Type Debt Transaction Amount $3,732,412 Transaction Round Undisclosed Proceeds Purposes … Continue reading “BioAegis Therapeutics Secures $3,732,412 New Round”
uConnect Secures $18,000 Seed Financing
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=1f1a143d-5195-46e6-b16c-7c168a93ee14 Date 2/10/2014 Company Name uConnect Mailing Address 155 Seaport Boulevard 16th Floor Boston, MA 02210 Company Description The recent rise in the cost of education has been prominent, yet student outcomes continue to suffer. Website http://www.gouconnect.com Transaction Type Accelerator Transaction Amount $18,000 Transaction Round Seed Proceeds Purposes The company will use … Continue reading “uConnect Secures $18,000 Seed Financing”
QuadWrangle Obtains $18,000 Seed Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=92c5cf0c-16f7-4194-9f93-8cb711cb5bb7 Date 2/10/2014 Company Name QuadWrangle Mailing Address 154 Commercial St. Boston, MA 02109 Company Description Based in Boston, MA, QuadWrangle is dedicated to making alumni happier than ever before and turning that happiness into institutional support. No matter where the winds may send an alum, they are always a graduate of … Continue reading “QuadWrangle Obtains $18,000 Seed Round”
CueThink Obtains $18,000 Seed Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=7e115a8b-c455-43d7-b8c6-e6b695d306ca Date 2/10/2014 Company Name CueThink Mailing Address 1 International Place Boston, MA 02110 Company Description We are team of passionate and driven product designers, curriculum specialists, game developers and data scientists. Website http://www.cuethink.com Transaction Type Accelerator Transaction Amount $18,000 Transaction Round Seed Proceeds Purposes The company will use the proceeds to … Continue reading “CueThink Obtains $18,000 Seed Funding Round”
Hackfit Boston 2014
From the organizers: “Hackfit will now be taking its adrenalized hackathon across the nation. On January 1st, the health-and-fitness-powered hackathon will be releasing tickets and details for its first four events of 2014 taking place in San Francisco, New York City, Philadelphia, and Boston. Hackfit is not your typical Hackathon. Dispelling the stereotype that most … Continue reading “Hackfit Boston 2014”
Boston Tech Roundup: DataXu, Imprivata, Flashnotes
A few financing deals that percolated up around the Boston area this week: —Boston-based advertising software company DataXu has raised another $10 million and added a new board member. The new cash was revealed in an SEC filing this week, and the company confirmed to the Boston Business Journal that the money came from existing … Continue reading “Boston Tech Roundup: DataXu, Imprivata, Flashnotes”
East Coast Biotech Roundup: Genocea, Eleven, NIH/Pharma, & More
A couple of local biotechs this week didn’t find their entrée to the public markets so friendly. Meanwhile, Big Pharmas all over the place were banding together to share their resources and run trials together. Those stories and more below: —Cambridge, MA-based vaccine developer Genocea Biosciences (NASDAQ: [[ticker:GNCA]]) was the first local biotech to price … Continue reading “East Coast Biotech Roundup: Genocea, Eleven, NIH/Pharma, & More”
How Do You Solve A Problem Like Samantha? The Lessons of “Her”
Warning: Extensive plot spoilers. Like any effective science fiction movie, Spike Jonze’s Her has sparked a lot of important conversation and criticism, about everything from user-interface design to misogyny in filmmaking. But the reviews I’ve read all seem to miss one key point. Considered as a product, not a person (and we’ll get back to … Continue reading “How Do You Solve A Problem Like Samantha? The Lessons of “Her””
Sometimes It Pays to Be A Jerk
The concepts in my Lean LaunchPad curriculum can be taught in a variety of classes–as an introduction to entrepreneurship all the way to a graduate level “capstone class.” I recently learned being tough when you select teams for a capstone class pays off for all involved. Here’s why. Our Lean LaunchPad class requires student teams … Continue reading “Sometimes It Pays to Be A Jerk”
Ericsson Acquires Boston Startup Azuki in Internet TV Wars
The Boston tech scene’s first big acquisition of 2014 just happened. Telecom giant Ericsson said today it is acquiring Azuki Systems, an Acton, MA-based maker of video-delivery software. Terms of the deal were undisclosed, but it could be an important one for the New England tech community. Azuki chairman Chris Lynch, reached by phone, declined … Continue reading “Ericsson Acquires Boston Startup Azuki in Internet TV Wars”
Eleven Prices IPO Below Projected Range, Grabs $50M
Eleven Biotherapeutics wants to prove that a drug it’s developing can go toe to toe with Allergan’s big-selling dry eye disease drug, Restasis. Wall Street, however, was tepid about the Cambridge, MA-based startup’s prospects to do so. Eleven has priced its IPO, selling 5 million shares to public investors at $10 apiece, raising a total … Continue reading “Eleven Prices IPO Below Projected Range, Grabs $50M”
5 Practical Tips for Startups to Develop a Solid Brand Reputation
Every company wants to build a strong brand. However, for startups in today’s crowded marketplace, it can be quite challenging to get a brand noticed and recognized. I believe it’s always a good idea to study the best brands in the world, and see how they do things. So here are a few key tips … Continue reading “5 Practical Tips for Startups to Develop a Solid Brand Reputation”
Kitsy Lane Obtains $1,051,000 New Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=49a7ab05-5284-4066-a663-66bfcef8d5e5 Date 2/6/2014 Company Name Kitsy Lane Mailing Address 2 Clock Tower Place Maynard, MA 01754 Company Description It’s all about the find, the hunt, the deal, the giving and receiving. And, it’s all about you. Kitsy Lane is made up of a community of Boutique Owners (from stay-at-home moms to professional … Continue reading “Kitsy Lane Obtains $1,051,000 New Financing Round”
Ericsson Acquires Azuki Systems for Undisclosed Sum
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=24dc8569-cbbd-49c9-b8d7-fc75aaa263c5 Date 2/6/2014 Company Name Azuki Systems Mailing Address 43 Nagog Park Acton, MA 01720 Company Description Leveraging the growing proliferation of digitized content, Web 2.0 enabled services and new wireless technologies, Azuki is leading the charge into a new era of mobile innovation and user experiences. We are changing the way … Continue reading “Ericsson Acquires Azuki Systems for Undisclosed Sum”
Vaccine Developer Genocea Prices IPO at $12 Per Share
If the question was how would public investors view a vaccine developer in today’s hot biotech IPO market, the answer Genocea Biosciences got last night was: cautiously. Cambridge, MA-based Genocea sold 5.5 million shares to public investors at $12 apiece, raising a total of $66 million before discounts due to underwriters. It marks a lukewarm … Continue reading “Vaccine Developer Genocea Prices IPO at $12 Per Share”
Punchbowl CEO: It’s All About Phones and Tablets, Not “Mobile”
It’s nice to connect the dots and spot important trends in the tech industry. Sometimes you only need one dot, though. In this case, it’s a company called Punchbowl. Founded in 2006, the Framingham, MA-based consumer software firm is surfacing with a couple bits of news today. One is that it has formed an exclusive … Continue reading “Punchbowl CEO: It’s All About Phones and Tablets, Not “Mobile””
Not All Student Entrepreneurs Drop Out
Today’s generation of students has a high exposure to the Internet, smartphones, social and many other technologies from a very young age. It is not uncommon to see college students tinkering with technology, starting digital startups, and making millions (and occasionally even billions). Some drop out of school to build their business, but not all. … Continue reading “Not All Student Entrepreneurs Drop Out”
DataXu Garners $9,999,999 New Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=3ac090ac-8510-4a37-9516-ff485eaad2b7 Date 2/5/2014 Company Name DataXu Mailing Address 281 Summer St. 4th Floor Boston, MA 02210 Company Description DataXu is a cutting-edge Cambridge, Massachusetts-based company formed by MIT alums and professionals. Our proprietary technology is a high-performance real-time, automated, self-learning decision-support system that matches advertisers, publishers, and web users at a rate … Continue reading “DataXu Garners $9,999,999 New Round”